Faculty Opinions recommendation of One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception.

Author(s):  
Kelly Culwell ◽  
Natasha Schimmoeller
Contraception ◽  
2017 ◽  
Vol 96 (2) ◽  
pp. 99-105 ◽  
Author(s):  
J.N. Sanders ◽  
D.K. Turok ◽  
P.A. Royer ◽  
I.S. Thompson ◽  
L.M. Gawron ◽  
...  

Author(s):  
Jane S. Sillman ◽  
Ajay K. Singh

The general internist needs to be up to date in contraception management. Each year nearly half of all pregnancies in the United States are unintended. Counseling about contraceptive options, provision of a back-up method, and information about emergency contraception can decrease the risk of unintended pregnancy. This chapter focuses on the aspects of contraception emphasized in Medical Knowledge Self-Assessment Program (MKSAP) 14: hormonal contraception, use of barrier methods, intrauterine devices, and emergency contraception.


Author(s):  
Kelly Cleland ◽  
Yan Che ◽  
Laura E Dodge ◽  
Alison Edelman ◽  
Norman Goldstuck ◽  
...  

1974 ◽  
Vol 77 (1_Suppla) ◽  
pp. S423-S434 ◽  
Author(s):  
Alejandro Zaffaroni

ABSTRACT In order to understand the special requirements for the assessment of human toxicity for hormone releasing intrauterine devices it is necessary first to describe the constitution of one such system. The uterine progesterone system developed in our laboratories is the hormonal intrauterine system which has been most extensively tested clinically. It releases 50 μg per day of progesterone in continuous form. It has been designed to have a one-year period of functional life and it constitutes the first once a year hormonal fertility control agent and the first hormonal system which is target specific. A number of unique features in the design and construction of this new and intrinsically safe hormonal system are described.


2021 ◽  
Vol 384 (4) ◽  
pp. 335-344
Author(s):  
David K. Turok ◽  
Alexandra Gero ◽  
Rebecca G. Simmons ◽  
Jennifer E. Kaiser ◽  
Gregory J. Stoddard ◽  
...  

2021 ◽  
Vol 10 (13) ◽  
pp. 2793
Author(s):  
Anna M. Jambrina ◽  
Pilar Rius ◽  
Pilar Gascón ◽  
Mercè Armelles ◽  
Mariona Camps-Bossacoma ◽  
...  

Numerous studies have been published suggesting that emergency contraception (EC) is used repeatedly, but a lack of information regarding the profile of users makes it difficult to evaluate actual consumer habits. The aim of this study was to obtain information regarding the profile of users who obtain EC and other factors that might play a role, and to provide criteria to evaluate and improve the strategies of current contraceptive programs. This was an observational one-year study based on surveillance data on the provision of EC to women of reproductive age in 60 community pharmacies in Catalonia, Spain. In total, 941 notifications of dispensation of EC in Catalonia were received. A total of 44.2% of users said it was not the first time that they had taken the medication (repeat user). The percentage of users who used condoms was lower in repeat users compared to first-time users (56.7% vs. 64.4%, p < 0.05). A total of 25.7% of users stated that they did not use any barrier contraceptive method. The use of natural methods in repeat users was 53.8% in the subgroup who requested the medication after 48 h, significantly higher than in users who obtained the medication within the first 24 h (p < 0.05). A high percentage of repeat users with risky sexual behaviors were detected, suggesting that new measures must be implemented to provide information for this method, together with educational and preventive strategies.


Sign in / Sign up

Export Citation Format

Share Document